Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 25,260 | 0 | 0 | 0 | 0 |
| Gross Profit | 25,260 | N/A | N/A | N/A | N/A |
| Operating Expenses | 31,040 | 25,579 | 25,936 | 23,582 | 22,151 |
| Operating Income | -5,780 | -25,579 | -25,936 | -23,582 | -22,151 |
| Other Income | 2,657 | 950 | 799 | 403 | 480 |
| Pre-tax Income | -3,123 | -24,629 | -25,137 | -23,179 | -21,671 |
| Income Tax | 3,551 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -6,674 | -24,629 | -25,137 | -23,179 | -21,671 |
| Net Income | $-6,674 | $-24,629 | $-25,137 | $-23,179 | $-21,671 |
| EPS Basic Total Ops | -0.21 | -0.79 | -0.80 | -0.74 | -0.69 |
| EPS Basic Continuous Ops | -0.21 | -0.79 | -0.80 | -0.74 | -0.69 |
| EPS Diluted Total Ops | -0.21 | -0.79 | -0.80 | -0.74 | -0.69 |
| EPS Diluted Continuous Ops | -0.21 | -0.79 | -0.80 | -0.74 | -0.69 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.79 | -0.80 | -0.74 | N/A |
| EBITDA(a) | $-5,476 | $-25,157 | $-25,452 | $-22,974 | $-21,619 |